Amyloid-β predominant Alzheimer's disease neuropathologic change

Gabor G Kovacs,Yuriko Katsumata,Xian Wu,Khine Zin Aung,David W Fardo,Shelley L Forrest,Alzheimer's Disease Genetics Consortium,James D Bowen,Paul K Crane,Gail P Jarvik,C Dirk Keene,Eric B Larson,Wayne C McCormick,Susan M McCurry,Shubhabrata Mukherjee,Neil W Kowall,Ann C McKee,Robert A Stern,Clinton T Baldwin,Lindsay A Farrer,Gyungah Jun,Kathryn L Lunetta,Lawrence S Honig,Jean Paul Vonsattel,Jennifer Williamson,Scott Small,Sandra Barral,Christiane Reitz,Badri N Vardarajan,Richard Mayeux,James R Burke,Christine M Hulette,Kathleen A Welsh-Bohmer,Marla Gearing,James J Lah,Allan I Levey,Thomas S Wingo,Liana G Apostolova,Martin R Farlow,Bernardino Ghetti,Andrew J Saykin,Salvatore Spina,Kelley M Faber,Tatiana M Foroud,Marilyn S Albert,Constantine G Lyketsos,Juan C Troncoso,Matthew P Frosch,Robert C Green,John H Growdon,Bradley T Hyman,Rudolph E Tanzi,Huntington Potter,Dennis W Dickson,Nilufer Ertekin-Taner,Neill R Graff-Radford,Joseph E Parisi,Ronald C Petersen,Bradley F Boeve,Mariet Allen,Minerva M Carrasquillo,Steven G Younkin,Ranjan Duara,Joseph D Buxbaum,Alison M Goate,Mary Sano,Arjun V Masurkar,Thomas Wisniewski,Eileen H Bigio,Marsel Mesulam,Sandra Weintraub,Robert Vassar,Jeffrey A Kaye,Joseph F Quinn,Randall L Woltjer,Lisa L Barnes,Lei Yu,Denis A Evans,Victor Henderson,Kenneth B Fallon,Lindy E Harrell,Daniel C Marson,Erik D Roberson,Charles DeCarli,Lee-Way Jin,John M Olichney,Ronald Kim,Frank M LaFerla,Edwin Monuki,Elizabeth Head,David Sultzer,Daniel H Geschwind,Harry V Vinters,Marie-Francoise Chesselet,Douglas R Galasko,James B Brewer,Adam Boxer,Anna Karydas,Joel H Kramer,Bruce L Miller,Howard J Rosen,William W Seeley,Jeffrey M Burns,Russell H Swerdlow,Linda J Van Eldik,Roger L Albin,Andrew P Lieberman,Henry L Paulson,Steven E Arnold,John Q Trojanowski,Vivianna M Van Deerlin,Laura B Cantwell,Amanda P Kuzma,John Malamon,Adam C Naj,Liming Qu,Gerard D Schellenberg,Otto Valladares,Li-San Wang,Yi Zhao,Ronald L Hamilton,M Ilyas Kamboh,Oscar L Lopez,James T Becker,Chuanhai Cao,Ashok Raj,Amanda G Smith,Helena C Chui,Carol A Miller,John M Ringman,Lon S Schneider,Thomas D Bird,Joshua A Sonnen,Chang-En Yu,Thomas Grabowsk,Elaine Peskind,Murray Raskind,Ge Li,Debby W Tsuang,Sanjay Asthana,Craig S Atwood,Cynthia M Carlsson,Mark A Sager,Nathaniel A Chin,Suzanne Craft,Nigel J Cairns,John C Morris,Carlos Cruchaga,Stephen Strittmatter,Eric M Reiman,Thomas G Beach,Matthew J Huentelman,John Hardy,John S K Kauwe,Hakon Hakonarson,Deborah Blacker,Thomas J Montine,William S Bush,Jonathan L Haines,Alan J Lerner,Xiongwei Zhou,Gary W Beecham,Regina M Carney,Michael L Cuccaro,John R Gilbert,Kara L Hamilton-Nelson,Brian W Kunkle,Eden R Martin,Margaret A Pericak-Vance,Jeffery M Vance,Amanda J Myers,James B Leverenz,Philip L De Jager,Mindy J Katz,Richard B Lipton,Valory Pavlik,Paul Massman,Eveleen Darby,Monica Rodriguear,Aisha Khaleeq,Donald R Royall,Alan Stevens,Marcia Ory,John C DeToledo,Henrick Wilms,Kim Johnson,Victoria Perez,Michelle Hernandez,Kirk C Wilhelmsen,Jeffrey Tilson,Scott Chasse,Robert C Barber,Thomas J Fairchild,Sid E O'Bryant,Janice Knebl,James R Hall,Leigh Johnson,Douglas Mains,Lisa Alvarez,Adriana Gamboa,David Paydarfar,John Bertelson,Martin Woon,Gayle Ayres,Alyssa Aguirre,Raymond Palmer,Marsha Polk,Perrie M Adams,Ryan M Huebinger,Joan S Reisch,Roger N Rosenberg,Munro Cullum,Benjamin Williams,Mary Quiceno,Linda Hynan,Janet Smith,Barb Davis,Trung Nguyen,Ekaterina Rogaeva,Peter St George-Hyslop,Peter T Nelson

DOI: https://doi.org/10.1093/brain/awae325

IF: 14.5

2024-10-18

Brain

Abstract:Different subsets of Alzheimer's disease neuropathologic change (ADNC), including the intriguing set of individuals with severe/widespread Aβ plaques but no/mild tau tangles (Aβ-predominant ADNC, or AP-ADNC), may have distinct genetic and clinical features. Analyzing National Alzheimer's Coordinating Center data, we stratified 1,187 participants into AP-ADNC (n = 95), low Braak primary age related tauopathy (PART; n = 185), typical-ADNC (n = 832), and high-Braak PART (n = 75). AP-ADNC differed in some clinical features and genetic polymorphisms in the APOE, SNX1, WNT3/MAPT , and IGH genes. We conclude that AP-ADNC differs from classical ADNC with implications for in vivo studies.

neurosciences,clinical neurology